Scilex Holding Company Current Liabilities
Scilex Holding Company (SCLX) had Current Liabilities of $512.24 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:LiabilitiesCurrent · last filed 2026-08-14
- 2026-06-30: Liabilities, Current $512.24M.
- 2026-03-31: Liabilities, Current $501.75M.
- 2025-12-31: Liabilities, Current $483.65M.
- 2025-09-30: Liabilities, Current $358.95M.
| Period end | Liabilities, Current | Liabilities, Current as first filed |
|---|---|---|
| 2026-06-30 | $512.24M 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $501.75M 10-Q · filed 2026-05-20 | |
| 2025-12-31 | $483.65M 10-Q · filed 2026-08-14 | |
| 2025-09-30 | $358.95M 10-Q · filed 2025-11-14 | |
| 2025-06-30 | $305.93M 10-Q · filed 2025-08-13 | |
| 2025-03-31 | $275.74M 10-Q · filed 2025-05-14 | |
| 2024-12-31 | $259.63M 10-K · filed 2026-04-10 | |
| 2024-09-30 | $281.54M 10-Q · filed 2025-01-17 | |
| 2024-06-30 | $255.45M 10-Q · filed 2024-08-13 | |
| 2024-03-31 | $252.73M 10-Q · filed 2024-05-13 | |
| 2023-12-31 | $250.38M 10-K · filed 2025-03-31 | |
| 2023-09-30 | $228.58M 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $103.58M 10-Q · filed 2023-08-11 | |
| 2023-03-31 | $64.60M 10-Q · filed 2023-05-12 | |
| 2022-12-31 | $44.84M 10-K · filed 2024-03-12 | |
| 2022-09-30 | $809.29K 10-Q · filed 2022-11-04 | |
| 2022-06-30 | $598.65K 10-Q · filed 2022-08-12 | |
| 2022-03-31 | $41.00K 10-Q · filed 2022-05-16 | |
| 2021-12-31 | $169.42M 10-K · filed 2023-03-07 | $208.70K 10-K · filed 2022-02-24 |
| 2021-09-30 | $43.57K 10-Q/A · filed 2021-12-08 | |
| 2021-06-30 | $20.02K 10-Q/A · filed 2021-08-24 | |
| 2021-03-31 | $17.21K 10-Q · filed 2021-07-23 | |
| 2020-12-31 | $180.76K 10-K · filed 2022-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| aTYR PHARMA INC (ATYR) | United States | $0.033B | -0.98 |
| Quince Therapeutics, Inc. (QNCX) | United States | $0.031B | |
| CEL SCI CORP (CVM) | United States | $0.030B | -0.81 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |